Fresh analysis reveals that people who discontinue blockbuster slimming jabs like semaglutide or tirzepatide can put back on shed pounds at a significantly accelerated pace than those who end conventional diet and exercise programs.
Research printed in a major medical journal shows that while overweight individuals often shed a large proportion of their total mass while undergoing treatment, the weight comes back at an average rate of 0.8 kg per month once they quit.
"Individuals using such medications must be aware of the risk of fast rebound weight gain when the medication ends," stated researcher Dr. Susan Jebb.
This pace of recovery means a return to starting weight in about one and a half years.
Comparing Treatments
The study, which examined 37 of trials involving thousands of patients, compared the results of the injectable medications with other pills.
The team note that individuals who shed pounds through lifestyle changes alone typically have a more gradual weight regain—approximately 0.1 kg a month—after stopping.
The Reason for the Quick Rebound
Doctors suggest the way of the injections accounts for the amplified rebound.
These medications mimic a body's own chemical called GLP-1, which moderates hunger.
"Long-term administration of GLP-1 levels several times higher than normal may cause the body to generate a reduced amount of its own natural GLP-1, and could reduce sensitivity to its effects," explained Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this GLP-1 'fix' means appetite is no longer kept in check, making overeating a significant risk."
A Lifelong Issue?
The NHS advise the jabs for individuals with obesity-related health risks, accompanied by recommended diet and exercise modifications.
Many experts contend that, due to the significant potential of weight regain, the therapy is often long-term.
This perspective is reinforced by pharmaceutical companies, who note that the results "highlight the chronic nature of excess weight," similar to managing conditions like high blood pressure.
Patient Experiences
Users who have stopped the medication describe a powerful return of appetite.
"I experienced a switch activating and you're instantly starving," described one woman.
The struggle is compounded if individuals have not developed lasting dietary or behavioural modifications during therapy.
Growing Use
Recent estimates suggest that millions of adults in the UK have tried weight-loss jabs in the past year, with interest continuing to grow.
- Use is greater among women than males.
- The middle-aged demographic shows the greatest usage rates.
- A large proportion access the medications through private healthcare rather than the NHS.
In conclusion, experts stress that while these medications are potent tools for weight loss, they are not a magic solution and long-term success relies on combined lifestyle support.